Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 20, 2021, Ms. Lily Zou notified Nature's Sunshine Products, Inc. (the "Company") of her resignation from the Company's Board of Directors. Ms. Zou had been designated for appointment to the Company's Board of Directors by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun") pursuant to the Stockholder Agreement between Fosun and the Company dated June 26, 2014. Ms. Zou's decision to resign is not due to any disagreement with the Company, including with respect to any matter relating to the Company's operations, policies or practices.

On September 22, 2021, the Company's Board of Directors appointed Ms. Shirley Wu to its Board of Directors. Ms. Wu was designated by Fosun and appointed to serve as a director until the next shareholders' meeting at which directors are elected.

Ms. Wu currently serves as Deputy CFO of Fosun, a position which she has held since June 2021. Ms. Wu joined Fosun in 2017, holding various positions prior to her current role. Prior to joining Fosun, Ms. Wu served as a partner in the audit function for KPMG Huazhen LLP Shanghai Branch. Ms. Wu earned a Bachelor of Economics degree from Shanghai University of Finance and Economics.

The Board of Directors determined that Ms. Wu is an independent director under the current standards for independence established by NASDAQ. In making this determination, the Board of Directors considered Ms. Wu's affiliation with Fosun, one of the Company's shareholders.

© Edgar Online, source Glimpses